21197 ⎘
Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant; Organic adjuvants CpG containing adjuvants; Oligonucleotide containing adjuvants
Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy
#1502De-immunized MOG (poly)peptide constructs
#1503Methods for treating and preventing infectious disease
#1504Methods for stimulating tlr irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responses
#1505CASB618 polynucleotides and polypeptides and their use
#1506Method for stimulating the immune, inflammatory or neuroprotective response
#1507Immunogenic compositions for Chlamydia trachomatis
#1508Method for preparation of vesicles loaded with biological material and different uses thereof
#1509Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMA
#1510Immunostimulatory oligonucleotide multimers
#1511Methods and compositions for inducing innate immune responses
#1512Immunostimulatory oligonucleotide multimers
#1513Immunostimulatory nucleic acids for inducing IL-10 responses
#1514Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
#1515Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides
#1516Immunostimulatory oligonucleotide multimers
#1517Methods of treating IgE-associated disorders and compositions for use therein
#1518Methods and products related to treatment and prevention of hepatitis C virus infection
#1519Immunostimulatory nucleic acid molecules
#1520Local nasal immunotherapy with allergen strip for allergic rhinitis
#1521Transcutaneous immunization without heterologous adjuvant
#1522Dry formulation for transcutaneous immunization
#1523Bacterial plasmid with immunological adjuvant function and uses thereof
#1524Efficacy of active immunotherapy by integrating diagnostic with therapeutic methods
#1525Immunostimulatory nucleic acid molecules
#1526Immunostimulatory nucleic acid molecules
#1527Compositions as adjuvants to improve immune responses to vaccines and methods of use
#1528Recombinant lentivirus encoding modified GP 120 signal sequences
#1529Immunostimulatory nucleic acid molecules
#1530Immunostimulatory nucleic acid molecules
#1531Novel use
#1532Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotide
#1533Vaccine
#1534Immunostimulatory viral RNA oligonucleotides
#1535HCV E1E2 vaccine compositions
#1536Immunostimulation by chemically modified RNA
#1537Immunostimulatory oligodeoxynucleotides
#1538Immunomodulatory oligonucleotides
#1539Immunotherapy compositions, method of making and method of use thereof
#1540Immunomodulatory oligonucleotides
#1541Immunomodulatory oligonucleotides
#1542Immunomodulatory oligonucleotides
#1543C-class oligonucleotide analogs with enhanced immunostimulatory potency
#1544Immunostimulatory nucleic acid molecules
#1545Cpg formulations and related methods
#1546Immunostimulatory nucleic acid molecules
#1547Immunostimulatory nucleic acid molecules
#1548Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
#1549Compositions and methods to initiate or enhance antibody and major-histocompatibility class I or class II-restricted t cell responses by using immunomodulatory, non-coding rna motifs
#1550Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
#1551Methods and products for enhancing epitope spreading
#1552Immunostimulatory nucleic acid molecules
#1553Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
#1554Oligodeoxynucleotide and its use to induce an immune response
#1555Microparticles with adsorbent surfaces, methods of making same, and uses thereof
#1556Method for inhibiting cancer cell proliferation or increasing cancer cell apoptosis
#1557Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
#1558Immunogenic HIV compositions and related methods
#1559Microparticles with adsorbent surfaces, methods of making same, and uses thereof
#1560Vaccine
#1561Immunostimulatory nucleic acid molecules
#1562Immunostimulatory nucleic acid molecules
#1563Methods related to immunostimulatory nucleic acid-induced interferon
#1564Immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides
#1565Synthetic conjugate of CpG DNA and T-help/CTL peptide
#1566Modified CpG oligodeoxynucleotide with improved immunoregulatory function
#1567Agents for enhancing the immune response
#1568Immunostimulatory nucleic acid molecules
#1569Modulation of immunostimulatory properties by small oligonucleotide-based compounds
#1570Immunostimulatory nucleic acid molecules
#1571Pharmaceutical composition for immunization against AIDS
#1572Immunostimulatory nucleic acid molecules
#1573Methods for treating and preventing infectious disease
#1574Cellular vaccines comprising adjuvants
#1575dsRNA induced specific and non-specific immunity in crustaceans and other invertebrates and biodelivery vehicles for use therein
#1576Immunostimulatory nucleic acid molecules
#1577Method for stabilising of nucleic acids
#1578Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences
#1579Immunostimulatory nucleic acid molecules
#1580Immunostimulatory nucleic acids
#1581Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv
#1582Immunostimulatory nucleic acid molecules
#1583Pharmaceutical composition comprising a polynucleotide and optionally an antigen especially for vaccination
#1584Programmed immune responses using a vaccination node
#1585Immunostimulatory nucleic acid molecules
#1586Immunostimulatory nucleic acid molecules
#1587Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
#1588Methods and products for treating HIV infection
#1589Immunomodulatory oligonucleotides
#1590Immunostimulatory nucleic acid molecules
#1591Vectors and methods for immunization or therapeutic protocols
#1592Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
#1593Vaccine
#1594Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
#1595Allogenic vaccine that contains a costimulatory polypeptide-expresing tumor cell
#1596Oligonucleotides, agents containing these oligonucleotides, and the use thereof
#1597Diagnostic reagents for human cytomegalovirus and methods of use
#1598Vaccines
#1599Vaccines using pattern recognition receptor-ligand:lipid complexes
#1600Immunomodulatory oligonucleotides
#1601Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents
#1602Immunomodulatory oligonucleotides
#1603Immunostimulatory nucleic acid molecules
#1604Vaccines
#1605Immunotherapeutic composition for prevention of obesity, nonalcoholic fatty liver disease and hypertriglyceridemia, and methods of use and preparation thereof
#1606Antibodies binding OX40 and uses thereof
#1607Nucleic acid-based adjuvant and porcine vaccine composition including the same